{
    "ticker": "INRO",
    "name": "Innova Therapeutics, Inc.",
    "description": "Innova Therapeutics, Inc. is a biotechnology company focused on developing innovative treatments for chronic diseases and conditions through advanced therapeutic solutions. Founded in 2015, the company specializes in the research and development of novel drug candidates that target key biological pathways involved in inflammation, cancer, and neurodegenerative disorders. Innova is committed to utilizing cutting-edge technologies, including gene therapy and regenerative medicine, to create transformative therapies that improve patient outcomes. The company\u2019s pipeline includes several promising candidates currently in various stages of clinical trials, aimed at addressing unmet medical needs. With a dedicated team of scientists and industry experts, Innova is poised to make significant contributions to the fields of biotechnology and healthcare. The company's mission is to enhance the quality of life for patients by delivering innovative therapeutic options that are both effective and safe.",
    "industry": [
        "Biotechnology",
        "Pharmaceuticals"
    ],
    "headquarters": "Boston, Massachusetts, USA",
    "founded": "2015",
    "website": "https://www.innovatherapeutics.com",
    "ceo": "Dr. Sarah Thompson",
    "social_media": {
        "twitter": "https://twitter.com/InnovaThera",
        "linkedin": "https://www.linkedin.com/company/innovatherapeutics/"
    },
    "investor_relations": "https://ir.innovatherapeutics.com",
    "key_executives": [
        {
            "name": "Dr. Sarah Thompson",
            "position": "CEO"
        },
        {
            "name": "John Smith",
            "position": "CFO"
        }
    ],
    "product_categories": [
        {
            "category": "Therapeutics",
            "products": [
                "INRO-101",
                "INRO-202"
            ]
        }
    ],
    "seo": {
        "meta_title": "Innova Therapeutics, Inc. | Innovative Biotech Solutions",
        "meta_description": "Explore Innova Therapeutics, Inc., a leader in biotechnology dedicated to developing innovative treatments for chronic diseases. Learn about our mission, pipeline, and impact.",
        "keywords": [
            "Innova Therapeutics",
            "Biotechnology",
            "Pharmaceuticals",
            "Drug Development",
            "Gene Therapy"
        ]
    },
    "faq": [
        {
            "question": "What does Innova Therapeutics specialize in?",
            "answer": "Innova Therapeutics specializes in developing innovative treatments for chronic diseases through advanced therapeutic solutions."
        },
        {
            "question": "Who is the CEO of Innova Therapeutics?",
            "answer": "Dr. Sarah Thompson is the CEO of Innova Therapeutics, Inc."
        },
        {
            "question": "Where is Innova Therapeutics headquartered?",
            "answer": "Innova Therapeutics is headquartered in Boston, Massachusetts, USA."
        },
        {
            "question": "What are the main products of Innova Therapeutics?",
            "answer": "Innova Therapeutics' main products include INRO-101 and INRO-202, which are currently in clinical trials."
        },
        {
            "question": "When was Innova Therapeutics founded?",
            "answer": "Innova Therapeutics was founded in 2015."
        }
    ],
    "competitors": [
        "EDIT",
        "CRSP",
        "ALNY",
        "NTLA"
    ],
    "related_stocks": [
        "AMGN",
        "BIIB",
        "GILD",
        "REGN"
    ]
}